传统中医药补肾固筋方对中老年膝骨关节炎患者IL-1、iNOS水平的影响和临床意义

目的观察补肾固筋方治疗膝骨关节炎IL-1、iNOS水平的研究。方法实验分两组进行,每组病例各92例,治疗8周,中药组口服补肾固筋方,西药组口服美洛昔康胶囊。收集患者治疗前后关节滑液及空腹血清,采用酶联免疫吸附法检测IL-1、iNOS的水平,观察治疗效果和不良反应。结果治疗前中药组和对照组IL-1、iNOS水平较治疗前显著增高;治疗后中药组关节液和血清IL-1、iNOS相比对照组显著降低（P〈0.05）;治疗后两组均未见明显血常规和肝肾功能异常。结论补肾固筋方在治疗中降低了IL-1、iNOS的水平及比值,不良反应少见,提示中药补肾固筋方通过调节细胞因子的表达水平来调控细胞凋亡和减轻软骨破坏,改善...

Full description

Saved in:
Bibliographic Details
Published in中国骨质疏松杂志 Vol. 21; no. 7; pp. 780 - 783
Main Author 张冲 高海燕 黄芸 王宁宁 李双成 刘玉杰
Format Journal Article
LanguageChinese
Published 河北省中医院骨三科,石家庄,050000%河北医科大学,石家庄,050017%解放军总医院骨科,北京,100853 2015
Subjects
IL-1（白介素-1）
iNOS（诱导型一氧化氮合酶）
膝骨关节炎
补肾固筋方
Interleukin-1
Knee osteoarthritis
Inducible nitric oxide synthase
补肾固筋方
IL-1(白介素-1)
iNOS(诱导型一氧化氮合酶)
Reinforcing kidney and strengthening ligament prescription
膝骨关节炎
Online AccessGet full text
ISSN1006-7108

Cover

More Information
Summary:目的观察补肾固筋方治疗膝骨关节炎IL-1、iNOS水平的研究。方法实验分两组进行,每组病例各92例,治疗8周,中药组口服补肾固筋方,西药组口服美洛昔康胶囊。收集患者治疗前后关节滑液及空腹血清,采用酶联免疫吸附法检测IL-1、iNOS的水平,观察治疗效果和不良反应。结果治疗前中药组和对照组IL-1、iNOS水平较治疗前显著增高;治疗后中药组关节液和血清IL-1、iNOS相比对照组显著降低（P〈0.05）;治疗后两组均未见明显血常规和肝肾功能异常。结论补肾固筋方在治疗中降低了IL-1、iNOS的水平及比值,不良反应少见,提示中药补肾固筋方通过调节细胞因子的表达水平来调控细胞凋亡和减轻软骨破坏,改善膝关节骨关节炎发生及发展。
Bibliography:ZHANG Chong,GAO Haiyan,HUANG Yun,WANG Ningning,LI Shuangcheng,LIU Yujie（1. Department of the Third Orthopedics, TCM Hospital of Hebei Province, Shijiazhuang 050000, China; 2. Hebei Medical University, Shijiazhuang 050017, China ;3. Department of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China）
Objective To observe the efficacy of reinforcing kidney and strengthening ligament prescription on the levels of IL-1and iNOS in knee osteoarthritis. Methods The experimental subjects were divided into two groups. Each group had 92 patients with the treatment for 8 weeks. Patients in Chinese medicine group received reinforcing kidney and strengthening ligament prescription,while patients in Western medicine group received oral Meloxicam capsules. The joint synovial fluid and fasting serum were collected before and after the treatment. The levels of IL-1 and iNOS were determined using ELISA method. The therapeutic efficacy and adverse reaction were observed. Re sults Before the treatment,the levels of IL-
ISSN:1006-7108